Skip to content

THE EFFECT OF BRAHMI VATI IN THE MANAGEMENT OF ESSENTIAL HYPERTENSION

THE EFFECT OF BRAHMI VATI IN THE MANAGEMENT OF ESSENTIAL HYPERTENSION A RANDOMISED DOUBLE BLIND CONTROLLED CLINICAL STUDY

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/08/006120
Enrollment
40
Registered
2015-08-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- essential hypertension

Interventions

Intervention1: Capsules Brahmi vati: 500mg twice a day after food , Orally for 30 days Control Intervention1: Capsules Sarpagandha ghana vati: 500mg twice a day after food , Orally for 30 days

Sponsors

Shree BMK Ayurved Mahavidyalaya Shahapur BelgaumKarnataka
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Criteria for the selection of the patients will be based on the criteria suggested by Joint National Committee (JNC)1 . 2. Stages of Pre hypertension & Stage I (Grade 1 & 2) Hypertension. 3. Patients between 20-70 years age of either sex

Exclusion criteria

Exclusion criteria: 1. Ischemic heart disease (IHD),Coronary heart disease (CHD),Coronary artery disease(CAD) and coarctation of aorta 2. Renal failure 3. Endocrine diseases, 4. Hypertension with cerebral complications e.g. hypertensive encephalopathy, cerebral haemorrhage, convulsive seizure. 5. Malignant hypertension. 6. Pregnant and Lactating female patients. 7. Patient on treatment for hypertension since 1 month.

Design outcomes

Primary

MeasureTime frame
1.Systolic and Diastolic Blood PressureTimepoint: 0,15,30 days

Secondary

MeasureTime frame
Hamilton Anxiety Rating Scale, Blood Lipid profile, Serum CreatinineTimepoint: 0, 30 days

Countries

India

Contacts

Public ContactDhanpat mishra

Shree BMK Ayurved Mahavidyalaya, Shahapur , Belgaum,Karnataka

ayurbasavaraj@gmail.com9448634660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026